Entera Bio (ENTX) Asset Utilization Ratio (2022 - 2025)
Entera Bio (ENTX) posted quarterly Asset Utilization Ratio of 0.0 for Q4 2025, down 88.1% year-on-year from 0.02 in Q4 2024, and down 62.4% on a QoQ basis from 0.01 in Q3 2025.
Entera Bio (ENTX) Asset Utilization Ratio (2022 - 2025) Analysis & Trends
Entera Bio (ENTX) has reported Asset Utilization Ratio for 4 consecutive years, with 0.0 the latest figure, recorded in Q4 2025.
- Quarterly Asset Utilization Ratio fell 88.1% year-over-year to 0.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0 (down 88.1% YoY) and the FY2025 annual result came in at 0.0, down 80.66% from the prior year.
- Asset Utilization Ratio fell to 0.0 in Q4 2025 per ENTX's latest filing, from 0.01 in the prior quarter.
- Over the last five years, Asset Utilization Ratio for ENTX reached as high as 0.02 in Q4 2024 and fell as low as 0.0 in Q3 2023.
- A 4-year average of 0.01 and a median of 0.01 in 2025 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2023 — Asset Utilization Ratio slumped 91.05% — and 2024, when it soared 656.23%.
- Year by year, Asset Utilization Ratio stood at 0.01 in 2022, then slumped by 84.24% to 0.0 in 2023, then soared by 1334.66% to 0.02 in 2024, then slumped by 88.1% to 0.0 in 2025.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.0, 0.01, and 0.01 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 0.69 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Entera Bio | 186.78 Mn | 182.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.01 |
| Jun 30, 2025 | 0.01 |
| Mar 31, 2025 | 0.01 |
| Dec 31, 2024 | 0.02 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.01 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.02 |
| Jun 30, 2022 | 0.02 |
| Mar 31, 2022 | 0.02 |